Introduction {#S0001}
============

Preoperative anxiety is a clinically significant problem for patients undergoing surgery, with a reported incidence ranging from 60% to 92%.[@CIT0001],[@CIT0002] Preoperative anxiety is associated with increased pain, nausea, vomiting, and risk of infection in the postoperative period.[@CIT0003]--[@CIT0005] Further, studies have shown a positive correlation between preoperative anxiety and postoperative pain intensity.[@CIT0006]--[@CIT0008] Enhanced allodynia and pain sensitivity due to stressful stimuli are collectively termed stress-induced hyperalgesia.[@CIT0009]--[@CIT0011] Some research have pointed out that gonadal steroid hormones significantly influence pain and anxiety levels differently in male and female. Estrogen, testosterone, and other gonadal hormones have a complex role in anxiety processes and the pain response.[@CIT0012],[@CIT0013] Although animal studies have investigated anxiety-induced hyperalgesia in males,[@CIT0014],[@CIT0015] the underlying mechanism in females remains unclear.

The rostral ventromedial medulla (RVM) is well recognized as a critical relay site for integrating descending modulatory influences on nociceptive input to dorsal horn neurons.[@CIT0016]--[@CIT0018] The RVM can facilitate or suppress nociceptive transmission through the actions of two distinct classes of neurons, ON-cells and OFF-cells, which, respectively, exert nociceptive and antinociceptive effects.[@CIT0019] Stress has been shown to produce thermal and mechanical hypersensitivity by activating pain-facilitating ON-cells in the RVM.[@CIT0020],[@CIT0021] Evidence indicates that ON-cells are activated by the peptide cholecystokinin (CCK).[@CIT0022] CCK has been shown to have both pro-nociceptive and anxiogenic properties, which are likely involved in the link between anxiety and hyperalgesia.[@CIT0023] Studies suggest CCK activates ON-cells, which produces hyperalgesia and allodynia via the CCK2 receptor.[@CIT0024] Additionally, treatment with CCK2 antagonists can reduce anxiety-induced hyperalgesia in humans.[@CIT0025] Studies have also shown that the CCK-induced increase in the spinal level of 5-hydroxyindoleacetic acid, a 5-hydoxytryptophan (5-HT) metabolite, can be blocked by pretreatment of the RVM with a CCK2 antagonist.[@CIT0026]

The serotonergic system from the RVM to the spinal cord is involved in descending facilitation during the development of persistent pain after tissue and nerve injury.[@CIT0027],[@CIT0028] The family of 5-HT receptors consists of seven subgroups and 15 receptor subtypes,[@CIT0029] including several subtypes associated with selective excitatory and inhibitory functions in neurons.[@CIT0017] However, it is unclear as to which 5-HT receptor subtypes in the spinal dorsal horn are associated with serotonergic modulation of preoperative anxiety-induced postoperative hyperalgesia in female rats. Activation of the 5-hydoxytryptophan 2B (5-HT2B) receptor in spinal dorsal horn neurons has been shown to be critical in the development of thermal and mechanical allodynia.[@CIT0030] Activation of 5-HT2 receptors and downstream protein kinase C (PKC) plays a role of relation to nociception in superficial dorsal horn neuron.[@CIT0031],[@CIT0032] PKCγ is specific to interneurons in the inner part of lamina II[@CIT0033] and widely participates in the processing of pain signals in spinal neuron.[@CIT0034],[@CIT0035] Translocation of PKC to the cell membrane is accompanied by increased phosphorylation of the NR1 subunit Ser-896 of the N-methyl-d-aspartate receptor (NMDAR) in the spinal cord.[@CIT0036] The NR1 subunit is phosphorylated by protein kinase A (PKA) on serine-890 and -897 and by PKC on Ser-896. The phosphorylation of NR1 subunit Ser-896 in spinal cord neurons can enhance pain sensitization. In this study, we investigated whether the CCK2 receptor in the RVM and spinal 5-HT2B receptor contribute to postoperative hyperalgesia after a single prolonged stress (SPS) procedure in female rats and observed the effect of antagonist on relieving postoperative hyperalgesia.

Materials and methods {#S0002}
=====================

Animals and estrogen replacement {#S0002-S2001}
--------------------------------

Adult female Sprague--Dawley rats, weighing from 250 to 300 g, were provided by the Laboratory Animal Centre of Drum Tower Hospital. The rats were housed in standard laboratory conditions with free access to food and tap water. Every effort was made to minimize suffering, and only the necessary number of rats was used to obtain valid results. This study was carried out in accordance with the principles of the Basel Declaration and recommendations of animal management regulations, State Scientific and Technological Commission of People's Republic of China. The protocol was approved by the Experimental Animals Welfare and Ethics Committee of Nanjing Drum Tower Hospital.

All of the female rats were anesthetized with sevoflurane and underwent bilateral ovariectomy. A small incision was made on bilateral sides of the back to expose the ovaries retroperitoneally. The ovaries were clamped and removed; the uterine tubes were ligated; then the skin was sutured.[@CIT0037] Prophylactic gentamicin 8 mg/mL, 1mL/kg was delivered i.p. following surgery. For estrogen replacement therapy, the ovariectomized rats were subcutaneously injected with 0.1 mg/kg/day of 17b-estradiol-3-benzoate (E2; Sigma, St. Louis, MO, USA), which has been previously shown to maintain an average concentration of plasma E2 between the nadir and peak levels of a normal estrous cycle.[@CIT0038]

SPS experiment and incisional surgery {#S0002-S2002}
-------------------------------------

In the SPS experiment, female rats were restrained for 2 hrs inside a plastic animal holder, and then they were placed in a plastic cylinder (30 cm in diameter and 50 cm tall), which was filled with water (25°C) to two-thirds of its height. The rats were then forced to swim individually for 20 mins on day 7 after estrogen replacement.[@CIT0039] Afterward, the rats were allowed to rest for 15 mins and then exposed to ether until they lost consciousness.[@CIT0040] A sham group of SPS rats was placed in another room without any further treatment.

On day 8 after estrogen replacement, incisional surgery was performed under sterile conditions following the procedure described by Brennan et al.[@CIT0041] Briefly, ovariectomized rats were first anesthetized with sevoflurane by a nose mask. After disinfection of the skin, a 1-cm longitudinal incision was made through the skin and fascia on the right hind paw, starting 0.5 cm from the edge of the heel and extending toward the toes. The plantaris muscle was elevated by forceps, leaving the muscle origin and insertion intact. Finally, the skin was closed with two mattress sutures using 5--0 nylon and the wound site was treated with aureomycin ointment.

Nociceptive behavioral tests {#S0002-S2003}
----------------------------

The paw withdrawal mechanical threshold (PWMT) was measured on day 6 (1day prior to SPS, baseline), as well as on days 8, 9, and 10 (2, 6, 24, and 48 hrs after incisional surgery, respectively). The rats were placed in plastic boxes with a wire mesh bottom and allowed to acclimate for 30 mins. PWMT was conducted by the "up-and-down" method using a set of von Frey filaments. Each von Frey filament was applied vertically with sufficient force to the plantar surface of the right hind paw, adjacent to the wound, for 6--8 s. Positive responses were defined by paw flinching or briskly withdrawing. The data were recorded and analyzed using the method described by Chaplan.[@CIT0042]

RVM microinjection procedure and intrathecal injection {#S0002-S2004}
------------------------------------------------------

In order to investigate the effects of drugs injected into RVM in animal, a microinjection system was constructed by the method described by Mitchell et al.[@CIT0043] Female rats were mounted on a stereotaxic frame under anesthesia with 10% chloral hydrate. After locating the bregma, a stainless-steel guide cannula was inserted unilaterally into the RVM and fixed to the skull using dental zinc cement. The stereotaxic coordinates for the RVM were −11.0 mm posterior to the bregma, ±0.6 mm lateral to the midline, and −7.5 mm ventral to the skull surface, according to the atlas of Paxinos and Watson (1986). A stainless steel dummy cannula was inserted into the guide cannula and remained in place when the guide cannula was not in use. After removal from the stereotaxic apparatus, the rats were placed in a thermally controlled cage to avoid hypothermia until they completely recovered from anesthesia. The animals were allowed to recover from the implantation surgery for 5 days prior to undergoing microinjection, and they were monitored for signs of motor impairment. Rats with any neurological dysfunction caused by the implantation procedure were excluded from subsequent experiments. The injection cannula was connected to a 5 µL Hamilton microsyringe. A total volume of 0.5  µL was injected over 2 mins. To ensure complete drug diffusion, the injector was left in place for an additional 2 mins before it was slowly removed.

Intrathecal injections were administered once a day from day 6 to day 8 after estrogen replacement. The procedures of intrathecal administrations were described as previously described.[@CIT0044] Following an optimal flexion of the rat lumbar spine under prone position, a 27-gauge needle attached to a 50 μL syringe (Hamilton, Reno, Nevada) was inserted into the midline of the lumbar 4--5 (L4-L5) intervertebral space of the rat.[@CIT0045] Neurobehavioral assessments were conducted after intrathecal administrations.

Drug preparation and experimental design {#S0002-S2005}
----------------------------------------

For estrogen replacement, we used E2 diluted in sesame seed oil. Experimental drugs administered via RVM microinjection included a CCK2 receptor agonist (CCK-8, Sigma) and a CCK2 receptor antagonist (YM022; Tocris, Bristol, UK), both of which were dissolved in saline. Experimental drugs administered intrathecally included a 5-HT2B receptor agonist (BW723C86; Tocris), a 5-HT2B receptor antagonist (RS127445; Tocris), and a PKCγ translocation inhibitor peptide (C37H65N9O13; Sigma). BW723C86 and C37H65N9O13 were dissolved in artificial cerebrospinal fluid (aCSF; in mmol/L: 130 NaCl, 3.5 KCl, 1.25 NaH~2~PO~4~, 24 NaHCO~3~, 1.2 CaCl~2~, 1.2 MgSO~4~, 10 ~D~-(±) glucose; pH 7.4) and RS127445 was dissolved in 1% dimethyl sulfoxide (DMSO). The dosages of E2 and other drugs were adopted according to our preliminary experiments and previous studies.[@CIT0030],[@CIT0046] There is no influence of 1% DMSO on the function of neurons in the superficial spinal dorsal horn.[@CIT0047] The schematic representation of the experimental design and time schedule of the protocol are shown in [Figure 1](#F0001){ref-type="fig"}.Figure 1The experimental design and time schedule in the study. Female rats were subjected to bilateral ovariectomy and received estrogen replacement for 10 days. CCK-8/YM022 microinjection in the RVM and BW723C86/RS127445/C37H65N9O13 intrathecal injection were administrated once per day from day 6 to 8 after the estrogen replacement. The single prolonged stress (SPS) was performed on day 7. Behavioral tests were conducted on day 6 (baseline value) prior to the incision surgery (on day 7), and on days 8, 9, and 10 after the incisional surgery. Samples were collected for immunofluorescence (IF) or Western blot (WB) analysis on day 10 after behavioral tests.

### Experiment 1 {#S0002-S2005-S3001}

The rats were randomly divided into four groups (n=6 per group): Group C underwent sham SPS and sham incisional surgery; Group I underwent incisional surgery, but not SPS; Group S underwent SPS, but not incisional surgery; and Group S+I underwent SPS on day 7 and incisional surgery on day 8 after estrogen replacement. The PWMT was measured on days 6, 8, 9, and 10. After the last behavioral test, the rats were sacrificed, and specimens of the RVM and spinal dorsal horn were collected for either immunofluorescence or Western blot analysis.

### Experiment 2 {#S0002-S2005-S3002}

The rats were randomly divided into seven groups (n=6 per group). All RVM microinjections were administered once a day from day 6 to day 8 after estrogen replacement. Group C underwent sham SPS and sham incisional surgery; Group I underwent incisional surgery, but not SPS; Group CCK-8 received an RVM microinjection of CCK-8 (20 pmol, 0.5 μL) and Group YM022 received an RVM microinjection of YM022 (2 pmol, 0.5 μL), but neither group underwent SPS or incisional surgery; Group CCK-8+I received microinjection of CCK-8 (20 pmol, 0.5 μL) and underwent incisional surgery, but not SPS; Group YM022+I received microinjection of YM022 (2 pmol, 0.5 μL) and underwent both SPS and incisional surgery; Group CCK-8+S received an RVM microinjection of CCK-8 (20 pmol, 0.5 μL) and underwent SPS without incisional surgery; Group Vehicle received an RVM microinjection of saline (0.5 μL) without SPS and incisional surgery. The PWMT was measured on days 6, 8, 9, and 10. After the last behavioral test, the rats were sacrificed, and specimens of the RVM were collected for either immunofluorescence or Western blot analysis.

### Experiment 3 {#S0002-S2005-S3003}

The rats were randomly divided into 10 groups (n=6 per group). All intrathecal injections were administered once a day from day 6 to day 8 after estrogen replacement, Group C underwent sham SPS and sham incisional surgery; Group I underwent incisional surgery, but not SPS; Group BW723C86 received intrathecal injections of BW723C86 (4 μM, 20 μL), Group RS127445 received intrathecal injections of RS127445 (10 μM, 20 μL), and Group C37H65N9O13 received intrathecal injections of C37H65N9O13 (50 μM, 20 μL); however, none of these 3 groups underwent SPS or incisional surgery; Group BW723C86+I received intrathecal injections of BW723C86 (4 μM, 20 μL) and underwent incisional surgery, but not SPS; Group RS127445+I received intrathecal injections of RS127445 (10 μM, 20 μL) and Group C37H65N9O13+I received intrathecal injections of C37H65N9O13 (50 μM, 20 μL), and both groups underwent SPS and incisional surgery; Group Vehicle1 received intrathecal injections of a CSF (20 μL) and Group Vehicle2 received intrathecal injections of 1% DMSO (20 μL), and both groups did not undergo SPS and incisional surgery. The PWMT was measured on days 6, 8, 9, and 10. After the last behavioral test, the rats were sacrificed, and specimens of the spinal dorsal horn were collected for either immunofluorescence or Western blot analysis.

Immunofluorescence {#S0002-S2006}
------------------

On day 10 after estrogen replacement, the rats were deeply anesthetized with intraperitoneal sodium pentobarbital (50 mg/kg) and perfused with 200 mL normal saline followed by 500 mL 0.1 M phosphate buffer containing 4% paraformaldehyde (pH =7.4). The brain and lumbosacral section of the spinal cord were quickly resected and placed in a fixative solution overnight. The RVM and spinal cord specimens were cut into sections. After washing with PBS, the sections were blocked with 10% FBS at room temperature for 1 hr. The sections were then incubated at 4°C for 48 hrs with the following primary antibodies: goat polyclonal antibodies against the CCK2 receptor (Abcam, Cambridge, UK, 1:200), goat polyclonal antibodies against the 5-HT2B receptor (Y-15; Santa Cruz Biotechnology, Dallas, TX, USA, 1:250), rabbit polyclonal antibodies against the PKCγ receptor (C-19; Santa Cruz Biotechnology, 1:250), and mouse monoclonal antibody against the NMDA receptor subunit NR1 (Millipore, Billerica, MA, USA, 1:1,000). After washing in PBS, sections were incubated with secondary fluorescent antibodies at room temperature for 1 hr. The RVM samples were incubated with NL 557-conjugated donkey anti-goat antibodies (R&D Systems, Minneapolis, MN, USA, 1:1,500). The spinal cord samples were incubated with secondary antibodies, including NL 557-conjugated donkey anti-goat, NL 493-conjugated donkey anti-rabbit (R&D Systems, 1:1,500), and Alexa Fluor 405-conjugated donkey anti-mouse (Abcam, 1:2,000) antibodies. Tissue sections were then washed, mounted on glass slides, and covered with coverslips. The specimens were examined by use of NA0.45×20 and NA0.75×20 objective with a confocal microscope (LSM710, ZEISS, Stuttgart, Germany). Thickness of obtained confocal sections was 10×5μm and 20×2μm. The images were captured and postprocessing was measured by ZEN2.3 software (ZEISS).

Western blot analysis {#S0002-S2007}
---------------------

After being deeply anesthetized with sevoflurane, the rats were euthanized. We took the brain tissue and put it in liquid nitrogen. After that, the brain was placed into the brain matrices and sliced with a 0.5 mm thickness, and then the RVM region of the brain tissue was taken out according to the atlas. The spinal dorsal horn segments (right dorsal part of L4--L5) were removed and stored in liquid nitrogen. The collected tissue samples were homogenized in a lysis buffer, the homogenate was centrifuged at 13,000 rpm for 10 mins at 4°C, and the supernatant was removed. Protein samples were separated by SDS-PAGE and then transferred onto a polyvinylidene difluoride membrane (Millipore). The filter membranes were blocked with 5% skim milk for 1 hr at room temperature and incubated overnight at 4°C with primary antibodies against the following antigens: CCK2 receptor (Abcam, 1:500), 5-HT2B receptor (Santa Cruz Biotechnology, 1:500), PKCγ (Santa Cruz Biotechnology, 1:1,000), and the antibody against p-NR1 subunit Ser-896, anti-NMDAR1 (phospho S896), purchased from Abcam (ab75680, 1:2,000). The membranes were then washed and incubated with secondary antibody for 1 hr at room temperature. β-actin was used as a loading control for total protein. Protein band visualization was achieved using the enhanced chemiluminescence method, and protein quantification was performed with Image-Pro Plus software.

Primary spinal cord dorsal horn neurons culture {#S0002-S2008}
-----------------------------------------------

Primary cultures of spinal cord superficial dorsal horn neurons from 14-day-old pregnant fetal rats were prepared following a previously described method.[@CIT0048] This results in cultures composed primarily of neurons from laminae II, although the presence of lamina III neurons cannot be entirely ruled out. The tissue fragments were incubated at 37°C for 30 mins in a medium containing Hank's balanced salt solution (HBSS) and papain (15 U/mL; Worthington Biochemical, Lakewood, NJ, USA), followed by a series of rinses, first with HBSS and then with a culture medium containing Neurobasal medium (Gibco, Grand Island, NE, USA), fetal calf serum (5%), heat-inactivated horse serum (5%), l-glutamax-1 (2 mM), B-27 (2%, Gibco), and glucose (20 mM). The resulting cell suspension was plated onto 12 mm poly-d-lysine- and collagen-coated coverslips and was cultured for 3--5 days in humidified air with 5% CO~2~ at 37°C.

Electrophysiological analysis {#S0002-S2009}
-----------------------------

The electrophysiological recordings were performed on cultured cells of the spinal cord.[@CIT0033],[@CIT0034] In our study, spinal cord superficial dorsal horn was dissected with a surgical blade cut in approximately lamina II. Although we isolated only the most superficial portion of the dorsal horn, the cultures may contain some cells from deeper laminae. In superficial dorsal horn neurons, the whole-cell Ca^2+^ channel currents (I~Ba~) were elicited by a 100-ms stepping voltage from a holding potential of −60 to 0 mV. Whole-cell patch-clamp electrophysiology was applied to measure the voltage-gated Ca^2+^ currents at room temperature (22--24°C) with a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). The Pclamp 10.2 program was used to extract and analyze all collected data. Coverslips were placed in a small laminar flow perfusion chamber and were continuously perfused with an extracellular solution. Signals were filtered at 1 kHz by a low-pass Bessel filter and digitized at 5 kHz. Series resistance and capacitance readings were collected directly from the amplifier after electronically subtracting the effects of capacitive transients. Series resistance was compensated to the maximal extent (at least 75%). Current traces were corrected using online P/6 trace subtraction. Currents were measured at their peak amplitude within the 200-ms test pulse and were used to determine the percentage of current decrease.

Statistical analysis {#S0002-S2010}
--------------------

Data were expressed as mean ± SD. Pain behaviors were analyzed by two-way repeated measures ANOVA. Bonferroni post-hoc tests were conducted to determine the source(s) of differences when significant main effects were observed. Kruskal--Wallis test was used for comparisons of the nonparametric data regarding Western blot. Treatment effects reflected by electric currents from the electrophysiological analysis were statistically analyzed by a paired or independent Student's *t*-test. All statistical analyses were performed using SPSS 17.0 software (SPSS Inc, Chicago, IL, USA), and *P*≤0.05 was set as the level of statistical significance.

Results {#S0003}
=======

Preoperative SPS-induced allodynia following incisional surgery in female rats {#S0003-S2001}
------------------------------------------------------------------------------

Group S, Group I, and Group S+I showed a decrease in the PWMT from 2 hrs to 48 hrs when compared with Group C ([Figure 2](#F0002){ref-type="fig"}). Further, PWMT nociceptive threshold levels decreased more in Group S+I than in Group S and Group I from 2 hrs to 48 hrs after incisional surgery. The same group did not induce significant changes in the PWMT among different times.Figure 2Paw withdraw mechanical threshold (PWMT) was measured at 2 hrs, 6 hrs, 24 hrs, and 48 hrs after the incisional surgery (n=6/each group). Group S, Group I, and Group S+I decreased in the PWMT at each time point after the incisional surgery. PWMT decreased more in Group S+I than in Group S and Group I (**A--D**). \**P*\<0.05, \*\**P*\<0.01 compared with Group C; ^&^*P*\<0.05, ^&&^*P*\<0.01 compared with Group S+I.

Neuronal receptors were observed under the confocal microscope. The CCK2 receptor was observed in the RVM neurons in Group S+I ([Figure 3](#F0003){ref-type="fig"}), and the triple immunofluorescence stained images of Group S+I showed the co-expression of the 5-HT2B receptor, NR1, and PKCγ in the superficial laminae of the spinal dorsal horn ([Figure 4](#F0004){ref-type="fig"}). Western blot analysis demonstrated that the expression of the CCK2 receptor in the RVM, as well as the 5-HT2B receptor, PKCγ, and p-NR1 in the spinal dorsal horn were significantly higher in Group S+I than in other groups ([Figure 5](#F0005){ref-type="fig"} and [Figure 6](#F0006){ref-type="fig"}).Figure 3Immunofluorescence stained images of CCK2 receptor in the RVM neurons in Group S+I which underwent SPS and incisional surgery (**A** and **D**), Group YM022+I (**B** and **E**) which received microinjection of YM022 and underwent both SPS and incisional surgery and Group CCK-8+I which received microinjection of CCK-8 and underwent incisional surgery (**C** and **F**). Scale bars equal 100 μm in a-c and 20 μm in d-f.Figure 4Immunofluorescence images of 5-HT2B receptor, PKCγ and NR1 receptor in spinal dorsal horn neurons. Co-expression of 5-HT2B receptor (**A** and **E**), PKCγ (**B** and **F**), and NR1 (**C** and **G**) in neurons of the spinal dorsal horn in Group S+I which underwent SPS and incisional surgery. Triple immunofluorescence stained images showed that 5-HT2B/PKCγ/NR1 (**D** and **H**) circumscribed in the spinal cord lamina II were co-localized, as indicated by white overlay. Scale bars equal 100 μm in a-d and 20 μm in e-h.Figure 5Western blot analysis of CCK2 receptor in RVM neurons of different groups (n=6/each). β-actin was used as an internal control. SPS experiment significantly upregulated the expression of CCK2 receptor in Group S compared with Group C and Group I. The expression of CCK2 receptor in Group S+I which underwent SPS and incisional surgery was significantly higher than in other groups (**A** and **B**). \**P*\<0.05 compared with Group C; ^\#^*P*\<0.05 compared with Group S; ^&^*P*\<0.05 compared with Group S+I.Figure 6Western blot analysis of 5-HT2B receptor, PKCγ, and p-NR1 in spinal dorsal horn neurons of different groups (n=6/each). β-actin was used as an internal control. The expressions of 5-HT2B receptor, PKCγ, and p-NR1 in spinal dorsal horn in Group S+I which underwent SPS and incisional surgery were significantly higher than in other groups (**A-D**). The expression level of PKCγ in Group I was higher than in Group C. \**P*\<0.05, \*\**P*\<0.01 compared with Group C; ^\#^*P*\<0.05 compared with Group I; ^&^*P*\<0.05, ^&&^*P*\<0.01 compared with Group S+I.

Upregulation of the CCK2 receptor in the RVM is associated with SPS-enhanced postoperative hyperalgesia in female rats {#S0003-S2002}
----------------------------------------------------------------------------------------------------------------------

To explore whether the upregulation of the CCK2 receptor in RVM neurons contributed to SPS-enhanced hyperalgesia in female rats, a selective CCK2 receptor agonist (CCK-8) and antagonist (YM022) were administered into the RVM ([Figure 7](#F0007){ref-type="fig"}). A decreased tolerance to nociceptive stimulus was observed in Group CCK-8 compared with Group C from 2 hrs to 48 hrs. Furthermore, Group CCK-8+I rats were relatively more sensitive to the same stimulus. No significant changes were found in the PWMT between Group YM022+I and Group I, and the nociceptive threshold of Group YM022+I was relatively lower than that of Group C from 2 hrs to 48 hrs. No significant differences were observed in the PWMT between Group Vehicle and Group C. The treatment of the same group did not induce significant changes in the PWMT among different times from 2 hrs to 48 hrs. Figure 7Paw withdraw mechanical threshold (PWMT) was measured at 2 hrs, 6 hrs, 24 hrs, and 48 hrs after the incisional surgery (n=6/each group). Decreased tolerance to nociceptive stimulus was observed in Group CCK-8, Group I, Group CCK-8+I, and Group YM022+I compared with Group C after the incisional surgery. Furthermore, Group CCK-8+I rats which received microinjection of CCK-8 and underwent incisional surgery were relatively more sensitive to the same stimulus compared with Group I (**A--D**). \*\**P*\<0.01 compared with Group C; ^\#\#^*P*\<0.01 compared with Group I; ^△^*P*\<0.05, ^△△^*P*\<0.01 compared with Group CCK-8+I.

Western blot analysis showed that microinjection of CCK-8 into the RVM significantly upregulated the expression of the CCK2 receptor in Group CCK-8 and Group CCK-8+I relative to Group C. Further, Group CCK-8+I showed greater upregulation of the expression of the CCK2 receptor than Group CCK-8. Conversely, RVM microinjection of YM022 markedly decreased the expression of the CCK2 receptor in the RVM ([Figure 8](#F0008){ref-type="fig"}). Microinjection of CCK-8 combined with SPS showed a higher intensity of CCK2 expression than Group C, and no significant changes were found in the expression of CCK2 compared with Group CCK-8 ([Figure 9](#F0009){ref-type="fig"}). Additionally, the CCK2 receptor was observed in immunofluorescence stained images of the RVM in Group CCK-8+I and Group YM022+I ([Figure 3](#F0003){ref-type="fig"}). These findings suggest that expression of the CCK2 receptor in the RVM is important for preoperative anxiety to mediate postoperative nociceptive stimulation in female rats.Figure 8Western blot analysis of CCK2 receptor in RVM neurons of different groups (n=6/each). β-actin was used as an internal control. Microinjection of CCK-8 in the RVM significantly upregulated the expression of CCK2 receptor in Group CCK-8 and Group CCK-8+I compared with Group C. Further, Group CCK-8+I which received microinjection of CCK-8 and underwent incisional surgery showed higher intensity of the CCK2 receptor than Group CCK-8 (**A** and **B**). \**P*\<0.05, \*\**P*\<0.01 compared with Group C; ^\#^*P*\<0.05 compared with Group CCK-8; ^△△^*P*\<0.01 compared with Group CCK-8+I.Figure 9Western blot analysis of CCK2 receptor in RVM neurons of different groups (n=6/each). β-actin was used as an internal control. The expressions of CCK2 receptor in Group CCK-8 and Group CCK-8+S were significantly higher than in Group C. No significant changes of CCK2 receptor expressions were found in the Group CCK-8 and Group CCK-8+S (**A** and **B**). \**P*\<0.05 compared with Group C.

SPS-enhanced postoperative allodynia triggered 5-HT2B receptor-mediated PKCγ upregulation and NR1 phosphorylation in dorsal horn neurons {#S0003-S2003}
----------------------------------------------------------------------------------------------------------------------------------------

To examine the role of the signaling pathway in the spinal cord dorsal horn in SPS-enhanced postoperative hyperalgesia, a selective 5-HT2B receptor agonist and antagonist, and a PKCγ translocation inhibitor peptide were administered by intrathecal injection ([Figure 10](#F0010){ref-type="fig"}). No significant difference in the PWMT was found between the sham and experimental groups prior to incisional surgery. The nociceptive threshold in Group BW723C86+I was lower than in Group RS127445+I and Group C37H65N9O13+I from 2 hrs to 48 hrs. No significant changes were found in the PWMT between Group RS127445+I and Group C37H65N9O13+I, and the nociceptive thresholds of these two groups were relatively lower than that of Group C from 2 hrs to 48 hrs. In addition, intrathecal injection without incisional surgery did not induce significant allodynia in Group BW723C86, Group RS127445, or Group C37H65N9O13 compared with the control group from 2 hrs to 48 hrs. No significant differences in the PWMT were observed in Group Vehicle1 or Group Vehicle2 compared with Group C. The treatment of the same group did not induce significant changes in the PWMT among different times from 2 hrs to 48 hrs.Figure 10Paw withdraw mechanical threshold (PWMT) was measured at 2 hrs, 6 hrs, 24 hrs, and 48 hrs after the incisional surgery (n=6/each group). BW723C86/RS127445/C37H65N9O13 intrathecal injection was administrated and the nociceptive threshold in the Group I, Group BW723C86+I, Group RS127445+I, and Group C37H65N9O13+I decreased. In addition, the mechanical allodynia exaggerated in Group BW723C86+I which received intrathecal injections of BW723C86 and underwent incisional surgery compared with other groups (**A--D**). \**P*\<0.05, \*\**P*\<0.01 compared with Group C; ^\#^*P*\<0.05, ^\#\#^*P*\<0.01 compared with Group I; ^▽▽^*P*\<0.01 compared with Group BW723C86+I.

Results from the Western blot analysis showed that intrathecal injection of BW723C86 significantly upregulated the expression of the 5-HT2B receptor, PKCγ, and p-NR1 in the dorsal horn after incisional surgery. Group BW723C86 and Group C37H65N9O13+I showed a higher intensity of 5-HT2B receptor expression than did the control group. Additionally, the expression level of PKCγ in Group I and Group RS127445+I was both distinctly higher than in Group C ([Figure 11](#F0011){ref-type="fig"}). The specificity of the primary antibodies was tested in the Western blot studies. For instance, the control group samples showed that the antibody of PKCγ was positive only in the molecular weight range corresponding to PKCγ, which proved the specificity of the antibody ([Figure 12](#F0012){ref-type="fig"}). Immunofluorescence stained image of Group BW723C86+I showed the 5-HT2B receptor in dorsal horn neurons. Furthermore, the expression of PKCγ, 5-HT2B receptor, and NR1 in dorsal horn was observed in Group RS127445+I ([Figure 13](#F0013){ref-type="fig"}).Figure 11Western blot analysis of 5-HT2B receptor, PKCγ, and p-NR1 in spinal dorsal horn neurons of different groups (n=6/each). β-actin was used as an internal control. Intrathecal injection of BW723C86 significantly upregulated the expression of 5-HT2B receptor, PKCγ, and p-NR1 in dorsal horn after incisional surgery compared with other groups (**A**--**D**). Group BW723C86 and Group C37H65N9O13+I showed a higher intensity of 5-HT2B receptor than the control group. The expressions level of PKCγ in Group I and Group RS127445+I was both distinctly higher than in Group C. \**P*\<0.05, \*\**P*\<0.01 compared with Group C; ^\#^*P*\<0.05 compared with Group I; ^△^*P*\<0.05, ^△△^*P*\<0.01 compared with Group BW723C86+I; ^▽^*P*\<0.05 compared with Group BW723C86.Figure 12The specificity of the primary antibody of PKCγ was tested in the Western blot studies. The control group samples showed that the antibody of PKCγ was positive only in the molecular weight range corresponding to PKCγ, which proved the specificity of the antibody.Figure 13Immunofluorescence images of 5-HT2B receptor (**A** and **E**), PKCγ (**B** and **F**) and NR1 receptor (**C** and **G**) in spinal dorsal horn neurons of Group RS127445+I which received intrathecal injections of RS127445 and underwent SPS and incisional surgery, and 5-HT2B receptor (**D** and **H**) in Group BW723C86+I which received intrathecal injections of BW723C86 and underwent incisional surgery. Scale bars equal 100 μm in a-d and 20 μm in e-h.

The electrophysiological recordings showed that adding BW723C86 to the bath significantly increased the peak I~Ba~ level by 18.65% over the basal level (n=7; [Figure 14A](#F0014){ref-type="fig"}, [B](#F0014){ref-type="fig"}). After removing BW723C86, the *I*~Ba~ amplitude partially recovered within 5 mins ([Figure 14B](#F0014){ref-type="fig"}, [C](#F0014){ref-type="fig"}). However, C37H65N9O13 did not have any significant effect on the *I*~Ba~ in superficial dorsal horn neurons (n=9; [Figure 15A](#F0015){ref-type="fig"}-[C](#F0014){ref-type="fig"}). Pretreatment with C37H65N9O13 completely abolished the BW723C86-induced *I*~Ba~ response (n=6; [Figure 15D](#F0015){ref-type="fig"}-[F](#F0014){ref-type="fig"}). This phenomenon suggests that the activation of the 5-HT2B receptor increases the I~Ba~ through the PKCγ pathway in superficial dorsal horn neurons.Figure 14Ca^2+^ channel currents have been measured in spinal cord dorsal horn neurons. The changes in I~Ba~ (**A**) and representative current traces (**B**) under control conditions, during exposure to BW723C86, and during washout. Numbers on the plot were correlated to points that were used for sample traces. The comparison of current density sets showed that the adding of 1 µM BW723C86 significantly increased I~Ba~ (**C**) \*\**P*\<0.01, compared with control.Figure 15Ca^2+^ channel currents have been measured in spinal cord dorsal horn neurons. The changes in I~Ba~ (**A**), representative current traces (**B**), and the comparison of current density sets (**C**) under control conditions and during exposure to C37H65N9O13. The changes in I~Ba~ (**D**), representative current traces (**E**), and the comparison of current density sets under control conditions, during exposure to C37H65N9O13, and during exposure to BW723C86 (**F**).

Discussion {#S0004}
==========

The present study showed that preoperative anxiety may induce postoperative hyperalgesia in female rats. Female rats that received an RVM microinjection of CCK-8 and underwent incisional surgery were relatively more sensitive to pain, and microinjection of YM022 into RVM relieved postoperative hyperalgesia. Furthermore, female rats treated with the intrathecal BW723C86 exhibited hyperalgesia until 48 hrs after incisional surgery, whereas the hyperalgesia quickly resolved after incisional surgery in rats that received an intrathecal injection of RS127445 or C37H65N9O13. These findings suggest that activation of CCK2 receptor in the RVM and spinal 5-HT2B receptor contributes to the hyperalgesia in female rats.

Preoperative anxiety among surgical patients is associated with acute postoperative pain.[@CIT0049] Although laboratory evidences have demonstrated the correlation between preoperative anxiety and postoperative pain in males,[@CIT0014],[@CIT0015] few studies were conducted to investigate this association and the underlying mechanism in females. In the present study, ovariectomized rats treated with estrogen replacement that underwent preoperative SPS conditioning and incisional surgery exhibited postoperative allodynia. The mechanical allodynia developed from 2 hrs to 48 hrs after the incision. Recently, several studies found that rats exposed to SPS exhibited long-lasting allodynia and hyperalgesia, and this phenomenon is considered to be associated with the activation of related receptor within the central nervous system neurons.[@CIT0050]

The RVM can facilitate nociception by activating pronociceptive ON-cells. Furthermore, blocking the activation of ON-cells reverses hyperalgesia following inflammation and nerve injury and prevents behavioral hyperalgesia after acute injury.[@CIT0051] The RVM has been shown to be critical for some forms of stress-induced hyperalgesia by activating pain-facilitating ON-cells.[@CIT0021] As the pro-nociceptive and anxiogenic properties, CCK is found in pain-related regions of the central nervous system, including the RVM.[@CIT0052] Local application of CCK into the RVM can activate the firing of ON-cells, which in turn produces behavioral allodynia and hyperalgesia via the CCK2 receptor;[@CIT0024] this effect can be attenuated by administering CCK2 antagonists.[@CIT0053] It is well known that anxiety can lead to the exacerbation of existing pain and reduce the efficacy of analgesic drugs in humans.[@CIT0054] Similarly, non-nociceptive stressful stimulation can induce hyperalgesia in animals.[@CIT0055] Previous studies have demonstrated the involvement of central cholecystokininergic systems and the CCK2 receptor in these phenomena. Moreover, intravenous administration of CCK receptor agonists produces panic-like anxiety in humans, which can be prevented by pretreatment with a CCK2 receptor antagonist.[@CIT0056] Additionally, the administration of CCK2 agonists that cross the blood--brain barrier causes anxiogenic behavior in rats.[@CIT0057] Thus, it appears that CCK is highly relevant in the mechanism linking anxiety with hyperalgesia, and CCK receptor antagonists are effective in reducing this hyperalgesia.[@CIT0025] However, most of these findings regarding anxiety-induced hyperalgesia have come from experiments in male animals.

In women, the luteal phase of the ovarian cycle is associated with changes in mood and anxiety levels, which raises the possibility that CCK may be involved in anxiety-induced hyperalgesia in females.[@CIT0023] In this study, rats in Group CCK-8+I were relatively more sensitive to pain than rats in Group C. The results of Western blot analysis revealed that the preoperative stress without the incisional surgery upregulated the expression of the CCK2 receptor protein within the RVM, and the expression further increased when the preoperative stress was followed by the incisional surgery. The reason for this phenomenon might be the sole preoperative stress-activated CCK2 receptor in female rats, and we speculate that plantar incision after preoperative stress might act as a positive feedback further activated CCK2 receptor within the RVM in this hyperalgesic effect. Additionally, the expression of the CCK2 receptor was significantly increased in Group CCK-8 and Group CCK-8+I as well as markedly decreased in Group YM022+I. Previous studies suggest that CCK facilitates hyperalgesia and allodynia via the CCK2 receptor, and this effect can be reduced by administering CCK2 antagonists.[@CIT0053] We found CCK-8 microinjection into the RVM elevated the CCK2 receptor protein, and the expression of the CCK2 receptor further increased when CCK-8 microinjection combined with incisional surgery. Of course, further studies are still needed to confirm this hypothesis. No significant difference in the intensity of CCK2 expression was found between Group CCK-8+S and Group CCK-8. Based on this finding, there is the possibility that the CCK2 receptor of RVM neurons increased to a certain extent after CCK-8 microinjection and did not increase further when CCK-8 microinjection combined with preoperative stress, which may be related to the different intensities of stimulation. Together, these results suggest that the CCK2 receptor in the RVM neurons is important for preoperative anxiety to mediate postoperative hyperalgesia in female rats. These findings support the likelihood that CCK increases the excitability of ON-cells that mediate descending pain facilitation through the CCK2 receptor in the RVM.

As a key brainstem region for controlling the response to noxious stimuli, the RVM is a major source of serotonergic input to the spinal cord.[@CIT0058] Exposure to noxious stimuli has been shown to activate serotonergic neurons in the RVM and to accelerate the turnover of 5-HT in the spinal cord.[@CIT0059] Furthermore, the CCK-induced increase in the spinal level of 5-hydroxyindoleacetic acid can be blocked by pretreatment of the RVM with a CCK2 antagonist.[@CIT0026] The downstream serotonergic projection system from the RVM to the spinal cord has a dual regulating effect on pain responses. The role of 5-HT in the inhibition or facilitation of pain responses is associated with the site (peripheral or central) and the 5-HT receptor subtype.[@CIT0060] Several subtypes of 5-HT receptors are associated with selective excitatory or inhibitory functions in neurons.[@CIT0017] Thus, it is likely that a certain subtype of the 5-HT receptor in the spinal cord facilitates preoperative anxiety-induced postoperative hyperalgesia in female rats.

A previous study reported that the 5-HT2B receptor in dorsal horn neurons is critically involved in thermal and mechanical allodynia.[@CIT0030] The 5-HT2B receptor utilizes a Gq-mediated signaling cascade, leading to activation of a signal transduction pathway that utilizes phospholipase C and diacyl glycerol/inositol trisphosphate.[@CIT0061] Diacyl glycerol acts as a second messenger that activates PKC, and inositol trisphosphate helps in the phosphorylation of some proteins. Upon stimulation, the bioactive PKC translocates from the cytoplasm to the cell membrane and phosphorylates corresponding receptors or ion channels, further regulating the permeability of the membrane.[@CIT0062],[@CIT0063] PKCγ is specific to interneurons in the inner part of lamina II[@CIT0033] and is widely involved in pain signal processing, as well as the formation, development, and maintenance of spinal neuron sensitization.[@CIT0034],[@CIT0035] Translocation of PKC to the cell membrane is accompanied by increased phosphorylation of the NR1 subunit Ser-896 of the NMDA receptor in the dorsal horn, which can enhance NMDA receptor ion channel function.[@CIT0064] The phosphorylation of NR1 in spinal cord neurons can increase neurons' sensitivity to pain stimulation and promote pain sensitization.[@CIT0036] The Ca^2+^ influx via calcium channels further regulates pacemaking activity, action potential burst firing, and pain transmission. Activated PKCγ, adhered onto or inserted into the cell membrane, promotes phosphorylation of NR1, which allows ion channels to remove the Mg^2+^ blockade and cause an influx of Ca^2+^.[@CIT0030] This influx of Ca^2+^ further activates intracellular calcium-dependent PKCγ. After the newly activated PKCγ translocates from the cytoplasm to the cell membrane, an increased number of phosphorylated NR1 receptors are activated and the influx of Ca^2+^ increases. This positive feedback loop ultimately leads to dorsal horn neuron hyperexcitability to noxious input and pain. The rats which received an intrathecal injection of RS127445 or C37H65N9O13 quickly resolved hyperalgesia after incisional surgery. We provided direct evidence that adding BW723C86 caused a significant increase in voltage-gated whole-cell Ca^2+^currents in superficial dorsal horn neurons. However, pretreatment with C37H65N9O13 completely abolished the BW723C86-induced I~Ba~ response. These observations suggest that preoperative anxiety-induced postoperative hyperalgesia in female rats occurs through the 5-HT2B receptor signaling pathway in spinal cord neurons.

Conclusion {#S0005}
==========

Together, the results of this study support the hypothesis that preoperative anxiety may induce postoperative hyperalgesia in female rats. During this process, increased expression of the CCK2 receptor likely enhances the excitability of neurons in the RVM, and 5-HT2B receptor signaling pathway in spinal cord neurons enhances the neurons' sensitivity to noxious stimuli.
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